SCHEMBL9894646

SCHEMBL9894646

O=CN1CC(CO)CC(c2ccc(C(F)(F)F)cc2)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 3/20 0.40
P2RY14 Q15391 2/20 0.40
ADRA2A P08913 1/20 0.40
DRD1 P21728 1/20 0.40
DRD5 P21918 1/20 0.40
ADRA1B P35368 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
HRH4 Q9H3N8 1/20 0.40
TACR1 P25103 1/20 0.37
F2R P25116 7/20 0.37
CHRM2 P08172 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28580878 0.83 HTR2C (0.47) HTR2CP2RY14ADRA2ADRD1DRD5
SCHEMBL29844054 0.77 GRIN2B (0.43) HTR2CP2RY14ADRA2ADRD1DRD5
SCHEMBL28818450 0.75 ADRA2A (0.49) HTR2CP2RY14ADRA2ADRD1DRD5
SCHEMBL29138789 0.75 ADRA2A (0.49) HTR2CP2RY14ADRA2ADRD1DRD5
SCHEMBL28818497 0.73 PROKR1 (0.46) HTR2CP2RY14ADRA2ADRD1DRD5
SCHEMBL3723936 0.72 F2R (0.63) TACR1F2R
SCHEMBL9926852 0.72 F2R (0.63) TACR1F2R
SCHEMBL22688514 0.71 P2RY14 (0.57) HTR2CP2RY14ADRA2ADRD1DRD5
SCHEMBL30945131 0.71 TACR1 (0.40) HTR2CP2RY14ADRA2ADRD1DRD5
SCHEMBL3968569 0.71 KMT2A (0.38) HTR2CP2RY14ADRA2ADRD1DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149694-A1 Substituted piperidines BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149694-A1 Substituted piperidines VHL, PIR, PIGO HTR2C 2089/4885P2RY14 368/4885ADRA2A 164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.